A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells

Justine R. Stehn, Nikolas K. Haass, Teresa Bonello, Melissa Desouza, Gregg Kottyan, Herbert Treutlein, Jun Zeng, Paula R. B. B. Nascimento, Vanessa B. Sequeira, Tanya L. Butler, Munif Allanson, Thomas Fath, Timothy A. Hill, Adam McCluskey, Galina Schevzov, Stephen J. Palmer, Edna C. Hardeman, David Winlaw, Vivienne E. Reeve, Ian DixonWolfgang Weninger, Timothy P. Cripe, Peter W. Gunning*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

120 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells'. Together they form a unique fingerprint.

Medicine & Life Sciences